387 related articles for article (PubMed ID: 11163394)
1. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
[TBL] [Abstract][Full Text] [Related]
2. Lateral recognition of a dye hapten by a llama VHH domain.
Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
[TBL] [Abstract][Full Text] [Related]
3. Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.
Desmyter A; Spinelli S; Payan F; Lauwereys M; Wyns L; Muyldermans S; Cambillau C
J Biol Chem; 2002 Jun; 277(26):23645-50. PubMed ID: 11960990
[TBL] [Abstract][Full Text] [Related]
4. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
[TBL] [Abstract][Full Text] [Related]
5. Comparison of llama VH sequences from conventional and heavy chain antibodies.
Vu KB; Ghahroudi MA; Wyns L; Muyldermans S
Mol Immunol; 1997; 34(16-17):1121-31. PubMed ID: 9566760
[TBL] [Abstract][Full Text] [Related]
6. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.
Decanniere K; Desmyter A; Lauwereys M; Ghahroudi MA; Muyldermans S; Wyns L
Structure; 1999 Apr; 7(4):361-70. PubMed ID: 10196124
[TBL] [Abstract][Full Text] [Related]
7. Affinity transfer to a human protein by CDR3 grafting of camelid VHH.
Inoue H; Iihara A; Takahashi H; Shimada I; Ishida I; Maeda Y
Protein Sci; 2011 Dec; 20(12):1971-81. PubMed ID: 21910150
[TBL] [Abstract][Full Text] [Related]
8. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).
Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB
J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607
[TBL] [Abstract][Full Text] [Related]
9. A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.
Deschacht N; De Groeve K; Vincke C; Raes G; De Baetselier P; Muyldermans S
J Immunol; 2010 May; 184(10):5696-704. PubMed ID: 20404276
[TBL] [Abstract][Full Text] [Related]
10. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
Saini SS; Farrugia W; Ramsland PA; Kaushik AK
Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
[TBL] [Abstract][Full Text] [Related]
11. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.
Saerens D; Pellis M; Loris R; Pardon E; Dumoulin M; Matagne A; Wyns L; Muyldermans S; Conrath K
J Mol Biol; 2005 Sep; 352(3):597-607. PubMed ID: 16095608
[TBL] [Abstract][Full Text] [Related]
12. Global analysis of VHHs framework regions with a structural alphabet.
Noël F; Malpertuy A; de Brevern AG
Biochimie; 2016 Dec; 131():11-19. PubMed ID: 27613403
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies.
Li X; Duan X; Yang K; Zhang W; Zhang C; Fu L; Ren Z; Wang C; Wu J; Lu R; Ye Y; He M; Nie C; Yang N; Wang J; Yang H; Liu X; Tan W
PLoS One; 2016; 11(9):e0161801. PubMed ID: 27588755
[TBL] [Abstract][Full Text] [Related]
14. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.
Fanning SW; Horn JR
Protein Sci; 2011 Jul; 20(7):1196-207. PubMed ID: 21557375
[TBL] [Abstract][Full Text] [Related]
15. Analysis and modeling of the variable region of camelid single-domain antibodies.
Sircar A; Sanni KA; Shi J; Gray JJ
J Immunol; 2011 Jun; 186(11):6357-67. PubMed ID: 21525384
[TBL] [Abstract][Full Text] [Related]
16. Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure.
Spinelli S; Desmyter A; Frenken L; Verrips T; Tegoni M; Cambillau C
FEBS Lett; 2004 Apr; 564(1-2):35-40. PubMed ID: 15094039
[TBL] [Abstract][Full Text] [Related]
17. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
[TBL] [Abstract][Full Text] [Related]
18. Single domain camel antibodies: current status.
Muyldermans S
J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
[TBL] [Abstract][Full Text] [Related]
19. A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers.
Kastelic D; Frković-Grazio S; Baty D; Truan G; Komel R; Pompon D
J Immunol Methods; 2009 Oct; 350(1-2):54-62. PubMed ID: 19744487
[TBL] [Abstract][Full Text] [Related]
20. Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae.
Gorlani A; Hulsik DL; Adams H; Vriend G; Hermans P; Verrips T
Protein Eng Des Sel; 2012 Jan; 25(1):39-46. PubMed ID: 22143875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
